Angiodynamics, Inc. (DE:UG2)
NASDAQ:UG2
UG2 Analyst Ratings
Strong Buy
3 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
UG2 Stock 12 Month Forecast
Average Price Target
€13.74
▲(40.90% Upside)
| Highest Price Target€13.74 | Average Price Target€13.74 | Lowest Price Target€13.74 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Canaccord Genuity
€13.74
Buy
40.90%
Upside
Reiterated
05/28/26
H.C. Wainwright
€13.74
Buy
40.90%
Upside
Reiterated
04/06/26
Freedom Capital Markets
€13.74
Buy
40.90%
Upside
Initiated
04/06/26
Lake Street
€20.61
Buy
111.35%
Upside
Reiterated
01/07/26
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Canaccord Genuity
€13.74
Buy
40.90%
Upside
Reiterated
05/28/26
H.C. Wainwright
€13.74
Buy
40.90%
Upside
Reiterated
04/06/26
Freedom Capital Markets
€13.74
Buy
40.90%
Upside
Initiated
04/06/26
Lake Street
€20.61
Buy
111.35%
Upside
Reiterated
01/07/26
Best Analysts Covering AngioDynamics
3 Months
1 Year
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
UG2 Analyst Recommendation Trends
Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
3
3
3
4
4
Buy
2
1
0
0
1
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
5
4
3
4
5
Each month's total comprises the sum of three months' worth of ratings.
UG2 Financial Forecast
UG2 Stock Forecast FAQ
What is DE:UG2’s average 12-month price target, according to analysts?
Based on analyst ratings, Angiodynamics, Inc.’s 12-month average price target is 13.74.
What is DE:UG2’s upside potential, based on the analysts’ average price target?
Angiodynamics, Inc. has 40.90% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Angiodynamics, Inc. a Buy, Sell or Hold?
Angiodynamics, Inc. has a consensus rating of Strong Buy, which is based on 3 buy ratings, 0 hold ratings and 0 sell ratings.
What is Angiodynamics, Inc.’s share price target?
The average share price target for Angiodynamics, Inc. is 13.74. This is based on 3 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €13.74 ,and the lowest forecast is €13.74. The average share price target represents 40.90% Increase from the current price of €9.75.
The highest analyst share price target is €13.74 ,and the lowest forecast is €13.74. The average share price target represents 40.90% Increase from the current price of €9.75.
What do analysts say about Angiodynamics, Inc.?
Angiodynamics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 3 Wall Streets Analysts.
How can I buy shares of Angiodynamics, Inc.?
To buy shares of DE:UG2, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.